Outcomes in Real-life After Initation of Treatment With Trixeo (Budesonide / Glycopyrronium / Formoterol)
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:February 13, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:February 13, 2024Recruiting
Condition(s):Musculoskeletal DiseasesLast Updated:June 7, 2022Recruiting
Condition(s):Spinal Disorders/InjuriesLast Updated:November 15, 2022Recruiting
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:February 1, 2024Recruiting
Condition(s):Chronic Liver DiseaseLast Updated:February 2, 2023Recruiting
Condition(s):Chronic Graft Versus Host DiseaseLast Updated:December 29, 2023Recruiting
Condition(s):Multiple SclerosisLast Updated:January 24, 2024Not yet recruiting
Condition(s):Cirrhosis; TumorLast Updated:September 29, 2023Recruiting
Condition(s):Fibromyalgia; Chronic Fatigue Syndrome; Multiple Sclerosis; HealthyLast Updated:February 14, 2024Recruiting
Condition(s):Somnolence Disorder, ExcessiveLast Updated:January 2, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.